Darbà, JosepAscanio, Meritxell2020-06-092020-10-312019-101473-7167https://hdl.handle.net/2445/164961Traditional drug payment schemes in Catalonia are generally based on the negotiation of fixed prices; however, disadvantages arise in the case of innovative therapies. Risk sharing agreements distribute potential health and economic uncertainties and high prices on access across the interested parts. (...)6 p.application/pdfeng(c) Informa Healthcare, 2019Risc (Economia)Indústria farmacèuticaRendimentEstudis de mercatRiskPharmaceutical industryPerformanceMarket surveysThe current performance-linked and risk sharing agreement scene in the Spanish region of Cataloniainfo:eu-repo/semantics/article6911132020-06-09info:eu-repo/semantics/openAccess